The patient was dosed at Austin Health in Melbourne, Australia, under the supervision of Professor Hui Gan. IPAX BrIGHT is assessing the safety and efficacy of TLX101-Tx in combination with ...

Reston, VA (August 11, 2025)--The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is proud to announce the launch of the Global Radiopharmaceutical Trial Finder a revolutionary, AI-powered ...

Regeneron Pharmaceuticals REGN announced that it has entered into a strategic collaboration with Telix Pharmaceuticals ...

Regeneron Pharmaceuticals (NASDAQ:REGN) has entered into a strategic collaboration with Telix Pharmaceuticals (NASDAQ:TLX) to develop and commercialize radiopharmaceutical therapies targeting cancer.

WILMETTE, Ill., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (MNPR), a clinical-stage biotechnology company focused on developing innovative treatments for patients with unmet medical ...

The partnership reflects a focus on precision oncology, seeking to enhance patient selection and assess treatment responses.

Regeneron Pharmaceuticals plans to expand its pipeline into radiopharmaceutical therapies through an up to $4.3 billion collaboration with Telix Pharmaceuticals to co-develop and co-commercialize ...

New data highlight predictive patient-derived models, resistance insights, and end-to-end translational workflows to improve translational oncology confidence ...

Financial terms include $40 million upfront for four programs, expansion options, and opt-out economics up to $535 million per program plus low double-digit royalties, totaling up to $2.1 billion.

WILMETTE, Ill., July 09, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients, today ...

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is proud to announce the launch of the Global Radiopharmaceutical Trial Finder a revolutionary, AI-powered platform designed to help ...

Nuclear physics, biotechnology and clinical practice have come a long way, and in the era of AI, these advances are leading to innovative solutions that are truly impacting lives. In the last two ...